Anonymous. Mild depression in general practice: time for a rethink?
Drug Ther Bull
2003; 41: 60–4.
Pincus HA, Davis WW, McQueen LE. ‘Subthreshold’ mental disorders. A review and synthesis of studies on minor depression and other ‘brand names’. Br J Psychiatry
1999; 174: 288–96.
Judd LL, Rapaport MH, Paulus MP, Brown JL. Subsyndromal symptomatic depression: a new mood disorder?
J Clin Psychiatry
1994; 55 (suppl): 18–28.
Ayuso-Mateos JL, Nuevo R, Verdes E, Naidoo N, Chatterji S. From depressive symptoms to depressive disorders: the relevance of thresholds. Br J Psychiatry
2010; 196: 365–71.
Rucci P, Gherardi S, Tansella M, Piccinelli M, Berardi D, Bisoffi G, et al. Subthreshold psychiatric disorders in primary care: prevalence and associated characteristics. J Affect Disord
2003; 76: 171–81.
Veerman JL, Dowrick C, Ayuso-Mateos JL, Dunn G, Barendregt JJ. Population prevalence of depression and mean Beck Depression Inventory score. Br J Psychiatry
2009; 195: 516–9.
Preisig M, Merikangas KR, Angst J. Clinical significance and comorbidity of subthreshold depression and anxiety in the community. Acta Psychiatr Scand
2001; 104: 96–103.
Rapaport MH, Judd LL. Minor depressive disorder and subsyndromal depressive symptoms: functional impairment and response to treatment. J Affect Disord
1998; 48: 227–32.
Blazer DG, Kessler RC, Swartz MS. Epidemiology of recurrent major and minor depression with a seasonal pattern. The National Comorbidity Survey. Br J Psychiatry
1998; 172: 164–7.
Kessler RC, Zhao S, Blazer DG, Swartz M. Prevalence, correlates, and course of minor depression and major depression in the National Comorbidity Survey. J Affect Disord
1997; 45: 19–30.
Cuijpers P, Smit F. Subthreshold depression as a risk indicator for major depressive disorder: a systematic review of prospective studies. Acta Psychiatr Scand
2004; 109: 325–31.
Penninx BW, Geerlings SW, Deeg DJ, van Eijk JT, van TW, Beekman AT. Minor and major depression and the risk of death in older persons. Arch Gen Psychiatry
1999; 56: 889–95.
Esposito E, Wang JL, Adair CE, Williams JV, Dobson K, Schopflocher D, et al. Frequency and adequacy of depression treatment in a Canadian population sample. Can J Psychiatry
2007; 52: 780–9.
Demyttenaere K, Bonnewyn A, Bruffaerts R, De Girolamo G, Gasquet I, Kovess V, Haro JM, et al. Clinical factors influencing the prescription of antidepressants and benzodiazepines: results from the European study of the epidemiology of mental disorders (ESEMeD). J Affect Disord
Cheng JS, Huang WF, Lin KM, Shih YT. Characteristics associated with benzodiazepine usage in elderly outpatients in Taiwan. Int J Geriatr Psychiatry
2008; 23: 618–24.
Srisurapanont M, Garner P, Critchley J, Wongpakaran N. Benzodiazepine prescribing behaviour and attitudes: a survey among general practitioners practicing in northern Thailand. BMC Fam Pract
2005; 6: 27.
Voyer P, Landreville P, Moisan J, Tousignant M, Preville M. Insomnia, depression and anxiety disorders and their association with benzodiazepine drug use among the community-dwelling elderly: implications for mental health nursing. Int J Psychiatr Nurs Res
2005; 10: 1093–116.
Valenstein M, Taylor KK, Austin K, Kales HC, McCarthy JF, Blow FC. Benzodiazepine use among depressed patients treated in mental health settings. Am J Psychiatry
2004; 161: 654–61.
Ackermann RT, Williams JW Jr. Rational treatment choices for non-major depressions in primary care: an evidence-based review. J Gen Intern Med
2002; 17: 293–301.
Oxman TE, Sengupta A. Treatment of minor depression. Am J Geriatr Psychiatry
2002; 10: 256–64.
Birkenhager TK, Moleman P, Nolen WA. Benzodiazepines for depression? A review of the literature. Int Clin Psychopharmacol
1995; 10: 181–95.
Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry
1960; 23: 56–62.
Montgomery SA, Åsberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry
1979; 134: 382–9.
Guy W. ECDEU Assessment Manual for Psychopharmacology. Superintendent of Documents, US Government Printing Office, US Department of Health, Education and Welfare Publication, 1976.
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ
2009; 339: b2535.
Norman GR. Issues in the use of change scores in randomized trials. J Clin Epidemiol
1989; 42: 1097–105.
Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6
. John Wiley & Sons, 2006.
Altman DG, Bland JM. Detecting skewness from summary information. BMJ
1996; 313: 1200.
Furukawa TA, Barbui C, Cipriani A, Brambilla P, Watanabe N. Imputing missing standard deviations in meta-analyses can provide accurate results. J Clin Epidemiol
2006; 59: 7–10.
Furukawa TA, Cipriani A, Barbui C, Brambilla P, Watanabe N. Imputing response rates from means and standard deviations in meta-analyses. Int Clin Psychopharmacol
2005; 20: 49–52.
Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ
2003; 327: 557–60.
Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schunemann HJ. What is ‘quality of evidence’ and why is it important to clinicians?
Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ
2008; 336: 924–6.
Barrett JE, Williams JW Jr, Oxman TE, Frank E, Katon W, Sullivan M, et al. Treatment of dysthymia and minor depression in primary care: a randomized trial in patients aged 18 to 59 years. J Fam Pract
2001; 50: 405–12.
Burrows AB, Salzman C, Satlin A, Noble K, Pollock BG, Gersh T. A randomized, placebo-controlled trial of paroxetine in nursing home residents with non-major depression. Depress Anxiety
2002; 15: 102–10.
Davidson JR, Giller EL, Zisook S, Overall JE. An efficacy study of isocarboxazid and placebo in depression, and its relationship to depressive nosology. Arch Gen Psychiatry
1988; 45: 120–7.
Judd LL, Rapaport MH, Yonkers KA, Rush AJ, Frank E, Thase ME, et al. Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder. Am J Psychiatry
2004; 161: 1864–71.
Paykel ES, Hollyman JA, Freeling P, Sedgwick P. Predictors of therapeutic benefit from amitriptyline in mild depression: a general practice placebo-controlled trial. J Affect Disord
1988; 14: 83–95.
Hollyman JA, Freeling P, Paykel ES, Bhat A, Sedgwick P. Double-blind placebo-controlled trial of amitriptyline among depressed patients in general practice. J R Coll Gen Pract
1988; 38: 393–7.
Paykel ES, Freeling P, Hollyman JA. Are tricyclic antidepressants useful for mild depression? A placebo controlled trial. Pharmacopsychiatry
1988; 21: 15–8.
Williams JW Jr, Barrett J, Oxman T, Frank E, Katon W, Sullivan M, et al. Treatment of dysthymia and minor depression in primary care: a randomized controlled trial in older adults. JAMA
2000; 284: 1519–26.
Frank E, Rucci P, Katon W, Barrett J, Williams JW Jr, Oxman T, et al. Correlates of remission in primary care patients treated for minor depression. Gen Hosp Psychiatry
2002; 24: 12–9.
Oxman TE, Barrett JE, Sengupta A, Katon W, Williams JW Jr, Frank E, et al. Status of minor depression or dysthymia in primary care following a randomized controlled treatment. Gen Hosp Psychiatry
2001; 23: 301–10.
Sullivan MD, Katon WJ, Russo JE, Frank E, Barrett JE, Oxman TE, et al. Patient beliefs predict response to paroxetine among primary care patients with dysthymia and minor depression. J Am Board Fam Pract
2003; 16: 22–31.
Moncrieff J, Kirsch I. Efficacy of antidepressants in adults. BMJ
2005; 331: 155–7.
National Collaborating Centre for Mental Health. Depression: Management of Depression in Primary and Secondary Care
. National Institute for Clinical Excellence, 2004.
Kroenke K. Minor depression: midway between major depression and euthymia. Ann Intern Med
2006; 144: 528–30.
Geiselmann B, Bauer M. Subthreshold depression in the elderly: qualitative or quantitative distinction?
2000; 41 (2
suppl 1): 32–8.
Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med
2008; 5: e45.
Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, Shelton RC, et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA
2010; 303: 47–53.
Cuijpers P, Smit F, van SA. Psychological treatments of subthreshold depression: a meta-analytic review. Acta Psychiatr Scand
2007; 115: 434–41.
World Health Organization. Benzodiazepines and Therapeutic Counselling: Report from WHO Collaborating Study. Springer Verlag, 1988.
Johnson DA. The use of benzodiazepines in depression. Br J Clin Pharmacol
1985; 19 (suppl 1): S31–5.